| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Leukemia | |||||
| Myelodysplastic Syndromes | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Leukemia, Myeloid | |||||
| Leukemia, Myeloid, Acute | |||||
| Myelodysplastic-Myeloproliferative Diseases | |||||
| Myeloproliferative Disorders | |||||
| Preleukemia | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Marrow Diseases | |||||
| Disease | |||||
| Hematologic Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Pathologic Processes | |||||
| Precancerous Conditions | |||||
| 4 | Interventions listed in this trial | ||||
| azacitidine | |||||
| sodium phenylbutyrate | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| 4-phenylbutyric acid | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antimetabolites | |||||
| Antimetabolites, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Sidney Kimmel Comprehensive Cancer Center | |||||
| National Cancer Institute (NCI) | |||||
|
